Sanofi
SNY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001121404
No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 691 institutions reported holding it in 13F filings for Q3 2026, worth $7.15B in total; Maverick Capital is the only superinvestor holding it.
Other share classesSNYNF
Key figures
- Market capADS ratio not in SEC data
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, −11 vs. previous quarter
- 692
- 13F valueReported value at the end of Q3 2026
- $7.15B
- Superinvestors holdingAt the end of Q3 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in EUR.
- Revenue, FY2025
- EUR 43.6B
- +6.2% year over year
- Net income, FY2025
- EUR 7.85B
- +39.7% year over year
- Free cash flow, FY2025
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 12.3M
- Shares sold short
- Change
- +679.6K
- +5.9% vs. previous
- Days to cover
- 2.85
- At average daily volume
Superinvestors holding SNY, Q3 2026
Go to the superinvestors tab1 superinvestor reports holding Sanofi on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Sanofi insiders from Form 4, newest first.
No open-market purchases or sales by Sanofi insiders are on file.
Top 10 13F holders, Q3 2026
See all 692 holdersThe largest institutional positions in Sanofi at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dodge & Cox | 15,668,529 | $646.0M | 0.35% | −12,419,745−44.2% | Reduced |
| Morgan Stanley | 14,900,060 | $614.3M | 0.03% | +4,197,533+39.2% | Added |
| Fisher Asset Management, LLC | 9,597,228 | $395.7M | 0.11% | −1,029,860−9.7% | Reduced |
| Bank of America Corp | 7,840,212 | $323.3M | 0.02% | −168,360−2.1% | Reduced |
| JPMorgan Chase & Co | 7,330,737 | $298.7M | 0.02% | +757,055+11.5% | Added |
| Invesco Ltd. | 6,271,955 | $258.6M | 0.02% | −527,006−7.8% | Reduced |
| Mondrian Investment Partners LTD | 5,652,139 | $233.0M | 5.16% | +129,575+2.3% | Added |
| Millennium Management LLC | 5,596,183 | $230.7M | 0.17% | +1,868,293+50.1% | Added |
| Federated Hermes, Inc. | 5,455,928 | $224.9M | 0.32% | +1,606,126+41.7% | Added |
| Brandes Investment Partners, LP | 4,306,275 | $177.5M | 1.22% | +169,858+4.1% | Added |
Holders of 5% or more of SNY
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Sanofi.
Politician trades
All politician trades in SNY7 members of Congress reported 12 trades in Sanofi since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 21, 2026 | Alan Armstrong Senate · OK | Buy | $15K-$50K |
| Oct 22, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |
| Sep 12, 2025 | Lisa C. McClain House · MI | Buy | $1K-$15K |
| Aug 13, 2025 | Lisa C. McClain House · MI | Buy | $1K-$15K |
| Aug 13, 2025 | Lisa C. McClain House · MI | Sell | $1K-$15K |

Senate · OK · Jul 21, 2026
Buy$15K-$50K

House · MI · Oct 22, 2025
Sell$1K-$15K

House · MI · Sep 12, 2025
Buy$1K-$15K

House · MI · Aug 13, 2025
Buy$1K-$15K

House · MI · Aug 13, 2025
Sell$1K-$15K